Related Experiment Video
Updated: Mar 2, 2026
11:19
Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
Published on: May 4, 2015
11.8K
Technologies for measuring HIV-1 drug resistance
Barbara Schmidt1, Klaus Korn, Hauke Walter
1Institute of Clinical and Molecular Virology, German National Reference Centre for Retroviruses, University of Erlangen-Nürnberg, Erlangen, Germany. baschmid@viro.med.uni-erlangen.de
HIV Clinical Trials
|May 29, 2002
Summary
Drug resistance testing for HIV-1 improves antiretroviral therapy response. Understanding resistance testing technologies and interpretation is crucial for optimizing patient treatment outcomes.
Area of Science:
- Virology
- Pharmacology
- Bioinformatics
Background:
- Drug resistance testing is vital for effective antiretroviral therapy (ART) in HIV-1 patients.
- Implementation of resistance testing into clinical guidelines highlights its importance.
- Variations in testing technologies and assays impact treatment outcomes.
Purpose of the Study:
- To emphasize the importance of understanding drug resistance testing technologies.
- To discuss the interpretation of resistance profiles based on mutations and clinical data.
- To explore the convergence of genotypic and phenotypic approaches for predicting clinical response.
Main Methods:
- Review of genotypic and phenotypic drug resistance testing technologies.
- Analysis of factors influencing the reliability and precision of resistance assays.
- Application of rules-based systems and bioinformatic techniques for resistance interpretation and prediction.
Main Results:
- Drug resistance testing significantly enhances ART response in HIV-1.
- Technical aspects and reliability of assays are critical for accurate resistance testing.
- Interpretation of resistance profiles is increasingly important due to evolving technologies.
Conclusions:
- Accurate interpretation of drug resistance testing is essential for optimizing ART.
- Bioinformatic approaches and clinical data integration are key to predicting treatment response.
- Development of large clinical databases is necessary for personalized antiretroviral therapy optimization.
